文献速递免疫规划卫生政策与健康促进

选定的Brighton协作组病例定义在低资源环境中的适用性:埃塞俄比亚亚的斯亚贝巴的一项前瞻性医院主动监测

Applicability of selected Brighton Collaboration case definitions in low-resource settings: A prospective hospital-based active surveillance in Addis Ababa, Ethiopia.
PubMed 文献 · Vaccine · 2024-06-21

在埃塞俄比亚最大转诊医院对2022年6月1日至2023年5月31日期间符合COVID-19疫苗接种条件且出现11种预设特殊关注不良事件(AESI)之一者进行前瞻性主动监测,共检出203例AESI,最常见为血栓与血栓栓塞(n=100,49%)和全身性惊厥(n=38,19%);96%的病例可归入1-3级(n=187)或5级(n=9),心包炎、脑炎、脊髓炎和全身性惊厥出现无法分类(4级)病例。作者认为Brighton协作组病例定义在埃塞俄比亚大型转诊医院>95%的病例中成功应用,但建议进一步在其他低资源环境中评估。

要点

  • 共检出203例AESI,血栓与血栓栓塞100例(49%),全身性惊厥38例(19%)。
  • 96%的病例归入1-3级(n=187)或5级(n=9) certainty。
  • 心包炎(n=2)、脑炎(n=2)、脊髓炎(n=2)和全身性惊厥(n=1)出现无法分类(4级)病例。

核心结论

  • Brighton协作组病例定义在埃塞俄比亚大型转诊医院>95%的病例中成功应用,全身性惊厥、心包炎和脑脊髓炎为例外。
  • 作者建议进一步在其他低资源环境中评估,尤其是农村或非转诊医院,以获取更多关于这些定义性能的见解,以便按需修订或调整。

研究设计与样本

  • 前瞻性医院主动监测,在埃塞俄比亚最大的转诊医院Tikur Anbessa专科医院开展,监测期为2022年6月1日至2023年5月31日。
  • 三名受训医生前瞻性识别符合COVID-19疫苗接种条件(无论是否接种疫苗)且从急诊和住院病房出现11种预设特殊关注不良事件(AESI)之一者。
  • 使用标准化数据收集表采集患者信息并分配确定性等级(LOC),无论COVID-19疫苗接种状态;采用描述性分析表征病例及各AESI达到的LOC。

主要发现

  • 共检出203例AESI病例,最常见为血栓与血栓栓塞(n=100,49%)和全身性惊厥(n=38,19%)。
  • 96%的病例归入1-3级(n=187)或5级(n=9)LOC。
  • 心包炎(n=2)、脑炎(n=2)、脊髓炎(n=2)和全身性惊厥(n=1)出现无法分类(4级)病例。

关键数值与推荐

  • Brighton协作组病例定义将确定性分为1级(最确定)至5级(非病例)。
  • 96%的病例归入1-3级(n=187)或5级(n=9)LOC,无法分类(4级)病例见于心包炎(n=2)、脑炎(n=2)、脊髓炎(n=2)和全身性惊厥(n=1)。

临床怎么用

  • 作者建议进一步在其他低资源环境中评估Brighton协作组病例定义,尤其是农村或非转诊医院,以获取更多关于这些定义性能的见解,以便按需修订或调整。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Standardizing case definitions for priority vaccine safety conditions facilitates uniform evaluation and consolidation of data obtained from different settings. The Brighton Collaboration case definitions (BCCD) were created to support this harmonization and enable classification from level 1 (most certain) to level 5 (not a case) of certainty. Assessing the performance of BCCD in practice is critical, particularly in resource-limited settings, where many new vaccines may be introduced without prior monitoring in high-income countries. We assessed the performance of BCCD in Addis Ababa, Ethiopia, as applicable to COVID-19 and other vaccines. METHODS: Active surveillance was conducted at Tikur Anbessa Specialized Hospital, the largest referral hospital in Ethiopia. During June 1, 2022-May 31, 2023, three trained physicians prospectively identified patients eligible for COVID-19 vaccination (regardless of vaccine receipt) who presented with one or more of eleven pre-specified adverse events of special interest (AESI) from the emergency department and inpatient wards. Standardized data collection forms were used to capture patient information and assign level of certainty (LOC), regardless of vaccination status for COVID-19. We conducted descriptive analysis to characterize cases and the LOCs reached for each AESI. RESULTS: We detected 203 AESI cases. The most detected conditions were thrombosis and thromboembolism (n = 100, 49 %) and generalized convulsions (n = 38, 19 %). Ninety-six percent of the cases were confirmed at levels 1-3 (n = 187) or level 5 (n = 9) LOC. Non-classifiable (level 4) cases were observed for pericarditis (n = 2), encephalitis (n = 2), myelitis (n = 2), and generalized convulsion (n = 1). CONCLUSION: The BCCD were successfully applied in > 95 % of cases in a large referral hospital in Ethiopia, with generalized convulsion, pericarditis, and encephalomyelitis as the exceptions. We recommend further evaluation in other low-resource settings, particularly in rural or non-referral hospitals, to gain additional insights into performance of these definitions for revision or adaptation, as needed.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Sintayehu K, Shaum A, Bonger ZT, et al. Applicability of selected Brighton Collaboration case definitions in low-resource settings: A prospective hospital-based active surveillance in Addis Ababa, Ethiopia. Vaccine. 2024. PMID: 38909000. doi:10.1016/j.vaccine.2024.06.046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。